Efficacy and safety of budesonide inhalation suspension in pediatric asthma: Japan, phase III clinical trials

被引：0
|
作者：
Akasawa, A
Mikawa, H
Nishima, S
机构：
[1] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[2] Kansai Denryoku Hosp, Sch Nursing Adv Practice, Osaka, Japan
[3] Fukuoka Natl Hosp, Natl Hosp Org, Fukuoka, Japan
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.366
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
356
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [31] Efficacy And Safety Of Budesonide Oral Suspension In A Pediatric Population: Pooled Data From A Phase 2 And Phase 3 Trial In Patients With Eosinophilic Esophagitis
    Gupta, Sandeep
    Mukkada, Vincent
    Dellon, Evan
    Gold, Benjamin
    Collins, Margaret
    Katzka, David
    Falk, Gary
    Lan, Lan
    Desai, Nirav
    Williams, James
    Hirano, Ikuo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB91 - AB91
  • [32] Efficacy of budesonide inhalation suspension (Pulmicort Respules™) in children with asthma previously treated with inhaled corticosteroids or other daily medications
    Galant, S
    Miller, CJ
    Mezzanotte, WS
    Fitzpatrick, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S241 - S241
  • [33] Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma
    Mellon, M
    Leflein, J
    Walton-Bowen, K
    Cruz-Rivera, M
    Fitzpatrick, S
    Smith, JA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) : 593 - 598
  • [34] Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma
    Skoner, DP
    Szefler, SJ
    Welch, M
    Walton-Bowen, K
    Cruz-Rivera, M
    Smith, JA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (02) : 259 - 268
  • [35] Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma
    Szefler, Stanley J.
    Baker, James W.
    Uryniak, Tom
    Goldman, Mitchell
    Silkoff, Philip E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (05) : 1043 - 1050
  • [36] Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials
    Sears, Malcolm R.
    Radner, Finn
    RESPIRATORY MEDICINE, 2009, 103 (12) : 1960 - 1968
  • [37] Clinical study of the treatment of variant asthma in children through nebulized inhalation of montelukast combined with different doses of budesonide suspension
    Wang, Hai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (10): : 7889 - 7895
  • [38] Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma
    Leflein, JG
    Gawchik, SM
    Galant, SP
    Lyzell, E
    Young, M
    Cruz-Rivera, M
    Walton-Bowen, K
    Smith, JA
    Fitzpatrick, S
    ALLERGY AND ASTHMA PROCEEDINGS, 2001, 22 (06) : 359 - 366
  • [39] REAL-LIFE EFFECTIVENESS AND SAFETY OF COMPARATOR BUDESONIDE INHALATION SUSPENSION IS NON-INFERIOR TO ORIGINATOR PRODUCT FOR ASTHMA PATIENTS
    Thomas, Vicky
    Price, David
    Yau, Simon
    Mcdonald, Rosie
    Chong, Camilla
    Gefen, Eran
    RESPIROLOGY, 2015, 20 : 20 - 20
  • [40] Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials
    Leppik, Ilo E.
    Wechsler, Robert T.
    Williams, Betsy
    Yang, Haichen
    Zhou, Sharon
    Laurenza, Antonio
    EPILEPSY RESEARCH, 2015, 110 : 216 - 220
12345